Cargando…

GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells

Gangliosides, the sialic acid-conjugated glycosphingolipids present in the lipid rafts, have been recognized as important regulators of cell proliferation, migration, and apoptosis. Due to their peculiar localization in the cell membrane, they modulate the activity of several key cell receptors, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergante, Sonia, Creo, Pasquale, Piccoli, Marco, Ghiroldi, Andrea, Menon, Alessandra, Cirillo, Federica, Rota, Paola, Monasky, Michelle M., Ciconte, Giuseppe, Pappone, Carlo, Randelli, Pietro, Anastasia, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126069/ https://www.ncbi.nlm.nih.gov/pubmed/30210549 http://dx.doi.org/10.1155/2018/4706943

Ejemplares similares

Chemical Activation of the Hypoxia-Inducible Factor Reversibly Reduces Tendon Stem Cell Proliferation, Inhibits Their Differentiation, and Maintains Cell Undifferentiation
por: Menon, Alessandra, et al.
Publicado: (2018)

Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies
por: Ghiroldi, Andrea, et al.
Publicado: (2018)

Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability
por: La Rocca, Paolo, et al.
Publicado: (2023)

HIF-1α Directly Controls WNT7A Expression During Myogenesis
por: Cirillo, Federica, et al.
Publicado: (2020)

Alterations of the Sialylation Machinery in Brugada Syndrome
por: Ghiroldi, Andrea, et al.
Publicado: (2022)

Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability
por: Randelli, Pietro, et al.
Publicado: (2016)

Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
por: Piccoli, Marco, et al.
Publicado: (2023)

Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI)
por: Piccoli, Marco, et al.
Publicado: (2022)

Calcium in Brugada Syndrome: Questions for Future Research
por: Monasky, Michelle M., et al.
Publicado: (2018)

Clinical Considerations for a Family with Dilated Cardiomyopathy, Sudden Cardiac Death, and a Novel TTN Frameshift Mutation
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α
por: Cirillo, Federica, et al.
Publicado: (2022)

Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses
por: Rota, Paola, et al.
Publicado: (2023)

Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site
por: Rota, Paola, et al.
Publicado: (2023)

Commentary: Next Generation Sequencing and Linkage Analysis for the Molecular Diagnosis of a Novel Overlapping Syndrome Characterized by Hypertrophic Cardiomyopathy and Typical Electrical Instability of Brugada Syndrome
por: Monasky, Michelle M., et al.
Publicado: (2017)

Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene
por: Monasky, Michelle M., et al.
Publicado: (2019)

Effects of the pulsed electromagnetic field PST® on human tendon stem cells: a controlled laboratory study
por: Randelli, Pietro, et al.
Publicado: (2016)

Epicardial ablation in genetic cardiomyopathies: a new frontier
por: Pappone, Carlo, et al.
Publicado: (2019)

Genotype–Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the SCN5A Gene
por: Monasky, Michelle M., et al.
Publicado: (2019)

Brugada Syndrome: Warning of a Systemic Condition?
por: D'Imperio, Sara, et al.
Publicado: (2021)

Novel SCN5A p.V1429M Variant Segregation in a Family with Brugada Syndrome
por: Monasky, Michelle M., et al.
Publicado: (2020)

Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019)

Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy?
por: Pappone, Carlo, et al.
Publicado: (2020)

Brugada Syndrome: Oligogenic or Mendelian Disease?
por: Monasky, Michelle M., et al.
Publicado: (2020)

Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value
por: Pappone, Carlo, et al.
Publicado: (2021)

Novel SCN5A p.W697X Nonsense Mutation Segregation in a Family with Brugada Syndrome
por: Micaglio, Emanuele, et al.
Publicado: (2019)

Physiopathological function of hematoside (GM3 ganglioside)
por: INOKUCHI, Jin-ichi
Publicado: (2011)

Secondary ganglioside GM2 accumulation in mucopolysaccharidoses
por: Sandhoff, Konrad
Publicado: (2021)

Ganglioside GM1 and the Central Nervous System
por: Guo, Zhongwu
Publicado: (2023)

Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths
por: Monasky, Michelle M., et al.
Publicado: (2021)

Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
por: Tonin, Rodolfo, et al.
Publicado: (2019)

The acidic hydrolysis of N-acetylneuraminic 4,5-oxazoline allows a direct functionalization of the C5 position of Neu5Ac2en (DANA)
por: Rota, Paola, et al.
Publicado: (2019)

Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
por: Seyfried, Thomas N., et al.
Publicado: (2010)

GM1 ganglioside-independent intoxication by Cholera toxin
por: Cervin, Jakob, et al.
Publicado: (2018)

Ganglioside GM2: a potential biomarker for cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2020)

Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
por: Chiricozzi, Elena, et al.
Publicado: (2021)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
por: Chowdhury, Suman, et al.
Publicado: (2022)

Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023)

SCN5A Nonsense Mutation and NF1 Frameshift Mutation in a Family With Brugada Syndrome and Neurofibromatosis
por: Micaglio, Emanuele, et al.
Publicado: (2019)

Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome
por: Kim, Jong Kuk, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a372l3pn2v5i1mprmn54ii921b